B-sure Traveler Towelette Solution
NDC Package 50289-9250-1
Package Information
B-sure Traveler Towelette (b-sure traveler) solution is gently apply to affected areas by patting and then discard. This formulation utilizes a solution delivery system. Marketed by Birchwood Laboratories Llc, this product is identified by NDC 50289-9250 and is authorized under FDA application M015.
Identification & Billing
- RxCUI: 844379 - witch hazel 50 % Medicated Pad
- RxCUI: 844379 - witch hazel 500 MG/ML Medicated Pad
- RxCUI: 844379 - witch hazel 50 % Medicated Wipes
Clinical Specifications
- Rectal - Administration to the rectum.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Regulatory & Marketing
Hierarchy Structure
- 50289 - Birchwood Laboratories Llc
- 50289-9250 - B-sure Traveler Towelette
- 50289-9250-1 - 4 g in 1 PACKET
- 50289-9250 - B-sure Traveler Towelette
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50289-9250-1 identifies a specific commercial package of 4 g in 1 packet of B-sure Traveler Towelette, a human over the counter drug labeled by Birchwood Laboratories Llc. This solution is formulated for rectal; topical use and contains witch hazel as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Birchwood Laboratories Llc on January 20, 2020. The current certification is valid through December 31, 2026.
How is this Birchwood Laboratories Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50289925001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.